Identifying widely covered drugs and drug coverage variation among medicare part D formularies

JAMA

Volumn 297, Issue 23, 2007, Pages 2596-2602

  Tseng, Chien Wen ^a,b   Mangione, Carol M ^c,d,e   Brook, Robert H ^c,d,e   Keeler, Emmett ^c   Dudley, R Adams ^f  

^a UNIVERSITY OF HAWAII   (United States)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c RAND CORPORATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CITALOPRAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; FLUOXETINE; FLUVOXAMINE; FUROSEMIDE; LABETALOL; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL; METOPROLOL ER; METOPROLOL TARTRATE; NADOLOL; NIFEDIPINE; PAROXETINE; PINDOLOL; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SOTALOL; TORASEMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; ANTIHYPERTENSIVE AGENT; GENERIC DRUG;

ARTICLE; DEPRESSION; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG FORMULARY; EVALUATION; HYPERLIPIDEMIA; HYPERTENSION; INTERNET; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; CLASSIFICATION; DRUG UTILIZATION; ECONOMICS; HEALTH INSURANCE; PUBLICATION; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; CALIFORNIA; DRUG COSTS; DRUG UTILIZATION; DRUGS, GENERIC; FORMULARIES; HAWAII; INSURANCE, PHARMACEUTICAL SERVICES; INTERNET; MEDICARE; UNITED STATES;

EID: 34250612983     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.23.2596     Document Type: Article

References (33)

1. Kaiser Family Foundation. Medicare - a primer. March 2007. http://www.kff.org/medicare/upload/7615.pdf. Accessed February 21, 2007.
2. Kaiser Family Foundation. Medicare at a glance. September 2005. http://www.kff.org/medicare/upload/1066-08.pdf. Accessed February 21, 2007.
3. Kaiser Family Foundation. National survey of physicians. November 2006. http://www.kff.org /kaiserpolls/upload/7584.pdf. Accessed February 21, 2007.
4. Kaiser Family Foundation. An in-depth examination of formularies and other features of Medicare drug plans. April 2006. http://www.kff.org/medicare/ upload/7489.pdf. Accessed February 21, 2007.
5. California HealthCare Foundation. The Medicare drug benefit: how good are the options? March 2006. http://www.chcf.org/documents/policy/ TheMedicareDrugBenefitHowGoodAreTheOptions.pdf. Accessed February 21, 2007.
6. California HealthCare Foundation. The Medicare drug benefit in California - facts and figures. September 2006. http://www.chcf.org/documents/insurance/ TheMedicareDrugBenefitInCalifornia.pdf. Accessed February 21, 2007.
7. Kaiser Family Foundation. The Medicare prescription drug benefit. November 2006. http://www.kff.org/medicare/upload/7044-05.pdf. Accessed February 21, 2007.
8. Kaiser Family Foundation. Benefit design and formularies of Medicare drug plans: a comparison of 2006 and 2007 offerings. November 2006. http://www.kff.org/medicare/upload/7589.pdf. Accessed February 21, 2007.
9. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166:1829-1835.
10. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291:2344-2350.
11. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-740.
12. Federman AD, Adams AS, Ross-Degnan D, et al. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA. 2001;286:1732-1739.
13. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94:1782-1787.
14. Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952-960.
15. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-429.
16. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354:2349-2359.
17. Wilson IB, Rogers WH, Chang H, et al. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000: results of a national study. J Gen Intern Med. 2005;20:715-720.
18. Kaiser Family Foundation. Seniors' early experiences with their new Medicare drug plans - June 2006. July 2006. http://www.kff.org/kaiserpolls/ pomr072706pkg.cfm. Accessed February 21, 2007.
19. Landon BE, Reschovsky JD, Blumenthal D. Physicians' views of formularies: implications for Medicare drug benefit design. Health Aff (Millwood). 2004;23:218-226.
20. Huskamp HA, Keating NL. The new Medicare drug benefit: formularies and their potential effects on access to medications. J Gen Intern Med. 2005;20:662-665.
21. Medical News Today. McClellan says CMS hopes to help Medicare beneficiaries understand new drug benefit better, but will not reduce number of available drug plans. February 14, 2006. http://www.medicalnewstoday.com/ medicalnews.php?newsid=37539. Accessibility verified May 21, 2007.
22. Peterson S, Gold M. Tracking Medicare health and prescription drug plans: monthly report for April 2007. May 1, 2007. http://www.kff.org/medicare/upload/ medicaretracking0407.pdf. Accessed May 24, 2007.
23. Kaiser Family Foundation. State health facts. http://www. statehealthfacts.org/cgi-bin/healthfacts.cgi? previewid=292&. Accessed February 21, 2007.
24. Kaiser Family Foundation. Medicare Part D enrollment and plan characteristics, 2006. Publication 7426-02. http://www.kff.org/medicare/upload/ 7426-02.pdf. Accessed February 21, 2007.
25. National Ambulatory Medical Care Survey. Health - United States 2005. http://www.cdc.gov/nchs/data/hus/hus05.pdf#092. Accessed February 21, 2007.
26. ePocrates Web site. http://www.epocrates.com. Accessibility verified May 21, 2007.
27. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384-391.
28. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000. Ann Intern Med. 2005;142:891-897.
29. The Cochrane Collaboration. The Cochrane Library. http://www.cochrane. org/index.htm. Accessed February 21, 2007.
30. The Medical Letter. The Medical Letter. http://www.medicalletter.com. Accessed February 21, 2007.
31. The Medical Letter. Treatment Guidelines. http://www.medicalletter.com. Accessed February 21, 2007.
32. Oregon Health & Science University. Drug Effectiveness Review Project. http://www.ohsu.edu/drugeffectiveness/reports/final.cfm. Accessed February 21, 2007.
33. Shrank WH, Ettner SL, Glassman P, et al. A bitter pill: formulary variability and the challenge to prescribing physicians. J Am Board Fam Pract. 2004;17:401-407.